7-FLUORO-8-CHLORO-5 -DIBENZO[B,E][1,4]DIAZEPINE DERIVATIVES AND USE THEREOF

This invention relates to medicine, in particular to pharmacology and psychiatry, and can be used for the manufacture of medications for treatment of treatment-resistant forms of schizophrenia. For this purpose we proposed the use of compounds 11-(piperazine-1-yl)-7-fluoro-8-chloro-5H-dibenzo[b,e][1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MOROZOVA, Margarita Alekseevna, BENIASHVILI, Allan Gerovich, ZAPOLSKI, Maksim Eduardovich
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MOROZOVA, Margarita Alekseevna
BENIASHVILI, Allan Gerovich
ZAPOLSKI, Maksim Eduardovich
description This invention relates to medicine, in particular to pharmacology and psychiatry, and can be used for the manufacture of medications for treatment of treatment-resistant forms of schizophrenia. For this purpose we proposed the use of compounds 11-(piperazine-1-yl)-7-fluoro-8-chloro-5H-dibenzo[b,e][1,4]diazepine, 11-(4-methyl piperazine-1-yl)-7-fluoro-8-chloro-5H-dibenzo[b,e][1,4]diazepine, pharmaceutically acceptable salts, hydrates or solvates thereof. The invention allows developing an effective medication, the use of which in treatment of treatment-resistant forms of schizophrenia allows for eliminating both the positive and negative symptoms of schizophrenia, and cognitive disorders, and the use of which does not cause severe side effects that limit its use, including sedation, tachycardia, orthostatism, agranulocytosis and sialorrhea.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3192513A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3192513A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3192513A13</originalsourceid><addsrcrecordid>eNrjZPA213XzCfUP8te10HX28AExTBV0XTydXP2i_KOddFxjow11TGJdPB2jXAM8_VwVXFyDPMMcQzzDXIMVHP1cFEKDXRVCPFyDXP3deBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAsaGlkamhsaOhMRFKAAh_LPg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>7-FLUORO-8-CHLORO-5 -DIBENZO[B,E][1,4]DIAZEPINE DERIVATIVES AND USE THEREOF</title><source>esp@cenet</source><creator>MOROZOVA, Margarita Alekseevna ; BENIASHVILI, Allan Gerovich ; ZAPOLSKI, Maksim Eduardovich</creator><creatorcontrib>MOROZOVA, Margarita Alekseevna ; BENIASHVILI, Allan Gerovich ; ZAPOLSKI, Maksim Eduardovich</creatorcontrib><description>This invention relates to medicine, in particular to pharmacology and psychiatry, and can be used for the manufacture of medications for treatment of treatment-resistant forms of schizophrenia. For this purpose we proposed the use of compounds 11-(piperazine-1-yl)-7-fluoro-8-chloro-5H-dibenzo[b,e][1,4]diazepine, 11-(4-methyl piperazine-1-yl)-7-fluoro-8-chloro-5H-dibenzo[b,e][1,4]diazepine, pharmaceutically acceptable salts, hydrates or solvates thereof. The invention allows developing an effective medication, the use of which in treatment of treatment-resistant forms of schizophrenia allows for eliminating both the positive and negative symptoms of schizophrenia, and cognitive disorders, and the use of which does not cause severe side effects that limit its use, including sedation, tachycardia, orthostatism, agranulocytosis and sialorrhea.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170719&amp;DB=EPODOC&amp;CC=EP&amp;NR=3192513A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170719&amp;DB=EPODOC&amp;CC=EP&amp;NR=3192513A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MOROZOVA, Margarita Alekseevna</creatorcontrib><creatorcontrib>BENIASHVILI, Allan Gerovich</creatorcontrib><creatorcontrib>ZAPOLSKI, Maksim Eduardovich</creatorcontrib><title>7-FLUORO-8-CHLORO-5 -DIBENZO[B,E][1,4]DIAZEPINE DERIVATIVES AND USE THEREOF</title><description>This invention relates to medicine, in particular to pharmacology and psychiatry, and can be used for the manufacture of medications for treatment of treatment-resistant forms of schizophrenia. For this purpose we proposed the use of compounds 11-(piperazine-1-yl)-7-fluoro-8-chloro-5H-dibenzo[b,e][1,4]diazepine, 11-(4-methyl piperazine-1-yl)-7-fluoro-8-chloro-5H-dibenzo[b,e][1,4]diazepine, pharmaceutically acceptable salts, hydrates or solvates thereof. The invention allows developing an effective medication, the use of which in treatment of treatment-resistant forms of schizophrenia allows for eliminating both the positive and negative symptoms of schizophrenia, and cognitive disorders, and the use of which does not cause severe side effects that limit its use, including sedation, tachycardia, orthostatism, agranulocytosis and sialorrhea.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPA213XzCfUP8te10HX28AExTBV0XTydXP2i_KOddFxjow11TGJdPB2jXAM8_VwVXFyDPMMcQzzDXIMVHP1cFEKDXRVCPFyDXP3deBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAsaGlkamhsaOhMRFKAAh_LPg</recordid><startdate>20170719</startdate><enddate>20170719</enddate><creator>MOROZOVA, Margarita Alekseevna</creator><creator>BENIASHVILI, Allan Gerovich</creator><creator>ZAPOLSKI, Maksim Eduardovich</creator><scope>EVB</scope></search><sort><creationdate>20170719</creationdate><title>7-FLUORO-8-CHLORO-5 -DIBENZO[B,E][1,4]DIAZEPINE DERIVATIVES AND USE THEREOF</title><author>MOROZOVA, Margarita Alekseevna ; BENIASHVILI, Allan Gerovich ; ZAPOLSKI, Maksim Eduardovich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3192513A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MOROZOVA, Margarita Alekseevna</creatorcontrib><creatorcontrib>BENIASHVILI, Allan Gerovich</creatorcontrib><creatorcontrib>ZAPOLSKI, Maksim Eduardovich</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MOROZOVA, Margarita Alekseevna</au><au>BENIASHVILI, Allan Gerovich</au><au>ZAPOLSKI, Maksim Eduardovich</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>7-FLUORO-8-CHLORO-5 -DIBENZO[B,E][1,4]DIAZEPINE DERIVATIVES AND USE THEREOF</title><date>2017-07-19</date><risdate>2017</risdate><abstract>This invention relates to medicine, in particular to pharmacology and psychiatry, and can be used for the manufacture of medications for treatment of treatment-resistant forms of schizophrenia. For this purpose we proposed the use of compounds 11-(piperazine-1-yl)-7-fluoro-8-chloro-5H-dibenzo[b,e][1,4]diazepine, 11-(4-methyl piperazine-1-yl)-7-fluoro-8-chloro-5H-dibenzo[b,e][1,4]diazepine, pharmaceutically acceptable salts, hydrates or solvates thereof. The invention allows developing an effective medication, the use of which in treatment of treatment-resistant forms of schizophrenia allows for eliminating both the positive and negative symptoms of schizophrenia, and cognitive disorders, and the use of which does not cause severe side effects that limit its use, including sedation, tachycardia, orthostatism, agranulocytosis and sialorrhea.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3192513A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 7-FLUORO-8-CHLORO-5 -DIBENZO[B,E][1,4]DIAZEPINE DERIVATIVES AND USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A20%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MOROZOVA,%20Margarita%20Alekseevna&rft.date=2017-07-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3192513A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true